Show simple item record

dc.contributor.authorCormican, Kathryn
dc.date.accessioned2013-12-06T15:06:36Z
dc.date.available2014-09-22T15:11:36Z
dc.date.issued2013-07
dc.identifier.citationO Connor, A. and Cormican, K. (2013) Product portfolio management: An analysis of a large medical device company 10th International Conference on Product Lifecycle Management Nantes, France, 2013-07-06- 2013-07-10en_US
dc.identifier.isbn978-3-642-41501-2
dc.identifier.urihttp://hdl.handle.net/10379/3896
dc.description.abstractThis paper focuses on product portfolio management in a large multinational medical device organisation. The contribution of this research is to provide insights into the nature, composition and decision making processes of product portfolios in a real world setting. The research is important because portfolio management decisions have a significant impact and influence the performance at each stage in the product life cycle. Results of the study indicate that portfolio management is a complex process in general but particularly challenging when dealing with technology development projects or innovative new products as unchartered waters are difficult to assess. We found that there are challenges with transparency and that stakeholders need fact based and information driven decisions. There is a need for better up front planning and systems to guide the process. Consistent criteria should be used to select and prioritise projects to facilitate better comparative ranking and allow for balanced portfolios, as well better resource distribution. However we also found that these criteria may change depending on the stage in the lifecycle.en_US
dc.formatapplication/pdfen_US
dc.language.isoenen_US
dc.publisherSpringer Berlin Heidelbergen_US
dc.relation.ispartof10th International Conference on Product Lifecycle Managementen
dc.subjectProduct portfolio managementen_US
dc.subjectBest practiceen_US
dc.subjectNew product developmenten_US
dc.subjectMedical device industryen_US
dc.titleProduct portfolio management: An analysis of a large medical device companyen_US
dc.typeBook chapteren_US
dc.typeConference Paperen_US
dc.date.updated2013-09-18T14:46:14Z
dc.identifier.doi0.1007/978-3-642-41501-2_3
dc.local.publishedsourcehttp://dx.doi.org/10.1007/978-3-642-41501-2_3en_US
dc.local.publisherstatementThe final publication is available at link.springer.comen_US
dc.description.peer-reviewedpeer-reviewed
dc.contributor.funder|~|
dc.internal.rssid5029117
dc.local.contactKathryn Cormican, Mechanical & Biomedical Eng, Eng-2046, New Engineering Building, Nui Galway. 3975 Email: kathryn.cormican@nuigalway.ie
dc.local.copyrightcheckedNo
dc.local.versionACCEPTED
nui.item.downloads890


Files in this item

Attribution-NonCommercial-NoDerivs 3.0 Ireland
This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. Please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.

The following license files are associated with this item:

Thumbnail

This item appears in the following Collection(s)

Show simple item record